If BRCA1-deficient breast cells are particularly sensitive to hormonal treatment, this could lead to a significantly higher risk of breast cancer compared with BRCA2 variant carriers associated with very early menopause and hormonal contraception use. This evidence concerns the gene BRCA2 and breast cancer.